Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders. [electronic resource]
Producer: 20200817Description: 570-576 p. digitalISSN:- 1558-822X
- Clinical Trials as Topic
- Diagnosis, Differential
- Disease Management
- Disease Susceptibility
- Humans
- Janus Kinases -- metabolism
- Lymphoproliferative Disorders -- diagnosis
- Molecular Targeted Therapy -- methods
- STAT Transcription Factors -- metabolism
- Signal Transduction -- drug effects
- T-Lymphocytes -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.